A placebo controlled, double-blind evaluation of levamisole in the reduction of the frequency, duration and severity of attacks in children suffering from recurrent upper respiratory tract infections.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples